OptimizeRx Corp·4

Apr 24, 10:18 AM ET

Besch Doug 4

4 · OptimizeRx Corp · Filed Apr 24, 2024

Insider Transaction Report

Form 4
Period: 2024-02-15
Besch Doug
Chief Product Officer
Transactions
  • Award

    Common Stock

    2024-02-15+4,0007,848 total
Footnotes (1)
  • [F1]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on February 15, 2025, which is the first anniversary of the date of grant.

Documents

1 file
  • 4
    wk-form4_1713968321.xmlPrimary

    FORM 4